HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
HDFC Mutual Fund · Equity · mandate: ≥80% in the named sector/theme · benchmark: —
AUM (all plans)
2,282 cr
TER direct / regular
1.11% / 2.19%
CAGR (full)
32.9%
Sharpe (full)
1.49
Sharpe (bull ≤Sep-24)
3.70
Sharpe (sideways Oct-24→)
0.69
Max drawdown
-14.2%
Months of data
34
Percentile ranks this fund within its peer pool; the leaderboard Score is
the weighted average of its fiscal-year percentiles (equity: active-return-rank blended
with IR-rank).
Equity curve
Drawdown
Fiscal-year record
FY
Return
vs category
Sharpe
months
FY22
—
—
—
0
FY23
—
—
—
0
FY24*
25.4%
2.7%
3.62
5
FY25
31.2%
24.1%
1.15
12
FY26
7.9%
9.1%
0.18
12
FY27*
26.3%
8.0%
6.18
5
Active/Fund returns are TOTALS over the months covered — never annualized
(FY27* is year-to-date; a * row covers only part of the year).
%ile is the fund's percentile within its peer pool for that year.
Monthly returns (%)
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Year
2023
+10.3
+4.4
+15.2
2024
+6.2
+3.2
-0.7
+2.2
-0.3
+5.1
+11.9
+7.4
+2.6
+1.0
+1.2
+3.5
+52.2
2025
-6.6
-8.2
+9.4
+0.7
+1.3
+3.9
+5.3
-3.7
-1.5
+3.3
+1.5
-1.7
+2.4
2026
-4.2
+7.9
-4.4
+7.5
+5.9
+5.8
+3.4
+1.4
+24.8
Quarterly average AUM & estimated net flows
Quarterly net flow estimate: AUM_q − AUM_(q−1)·(1+quarter return). AUM shown is the quarter AVERAGE (AMFI central disclosure). Positive = net inflows, ₹cr.
Source: AMFI's official all-scheme NAV history (portal report; official NAV history, net of TER by
construction). Monthly returns are month-end NAV chains; stale prints (>7 days before
month-end) drop out rather than carry. Benchmark series are the median of plain-vanilla
direct-plan index funds tracking each index (TRI minus ~10-25bp/yr tracking drag — verified
against true-TRI chains). Direct plans, growth option only. Sharpe uses rf 6%, arithmetic
monthly convention. Independence: all figures are computed from mandatory public disclosures with a
fixed methodology applied identically to every fund — no fund can pay for inclusion,
exclusion, placement, or altered presentation, and any material commercial relationship
will be disclosed on the affected pages.
Nothing here is investment advice; past performance does not
predict future returns. Generated 2026-08-25 05:37Z · data through Aug 2026 · leaderboard
· PMS leaderboard